Clinical Laboratory Services
Over two decades of clinical laboratory experience
Our clinical laboratory services are designed to support your clinical work. Whether you are developing a new drug, cell therapy, or want to preserve your own iPSCs for future therapeutic use, our scientists can help. As pioneers in human fresh tissue testing and stem cell research, we have the experience and expertise to fulfil your clinical goals.
Clinical sample processing
REPROCELL has a proven track record as one of the key sample processing facilities to conduct global multicentric clinical trials. Processing laboratories are vital for clinical trials due to the perishable nature of samples. It is therefore essential to work with partners who can guarantee sample integrity within a given timeframe. With over two decades of experience in human tissue handling, our scientists can support your clinical trials.
Precision medicine promises to improve drug performance by stratifying the patient population. However, these clinical trials are expensive and time-consuming. Using human fresh tissue research, our scientists can stratify your target population at the preclinical stage, before clinical trials begin. By identifying drug respondents at an early stage, we can help you better inform your precision medicine strategies before clinical trial.
Primary cell isolation
Primary cells are ideal cell models for a variety of research, including cell biology, disease mechanisms, and drug screening.
REPROCELL can source fresh human material from healthy and disease state donors from our global tissue network. With access to both Miltenyi and EasySep Cell Selection platforms, our scientists can provide comprehensive and custom cell isolation services.
Induced pluripotent stem cell (iPSC) therapies have the potential to treat diseases previously thought incurable. However, tissue collection for iPSC generation can be uncomfortable and invasive. Our Personal iPS service allows the generation of your own, personal stem cells from urine, blood, or dental pulp. By offering non-invasive forms of tissue collection vulnerable donors, such as the very young or elderly, are not excluded from iPSC generation.